Benefiting from the homotypic membrane fusion capacity of the cell membrane coating, the nanomicelles enabled active targeting of breast cancer, anchoring IR780 to the breast cancer cell membrane, while releasing L-Arg and Rapa-loaded ELP micelles into the cytoplasm. This evidence concerns the gene NR5A1 and breast carcinoma.